Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by funky99on Jan 08, 2015 5:02pm
270 Views
Post# 23299918

NEWS: VANC PHARMACEUTICALS RE-PRICES OPTIONS AND GRANTS INCE

NEWS: VANC PHARMACEUTICALS RE-PRICES OPTIONS AND GRANTS INCEhttps://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aNPH-2242735&symbol=NPH&region=C


 

Vanc Pharmaceuticals reprices, grants stock options

2015-01-08 16:25 ET - News Release

 

Mr. Arun Nayyar reports

VANC PHARMACEUTICALS RE-PRICES OPTIONS AND GRANTS INCENTIVE STOCK OPTIONS

Vanc Pharmaceuticals Inc., further to its news release dated Dec. 18, 2014, has repriced the 1.2 million incentive stock options from 16 cents to 20 cents. The company has also set aside an aggregate of 150,000 incentive stock options to a director to purchase shares of the company at an exercise price of 20 cents per share for a period of five years.

We seek Safe Harbor.

© 2015 Canjex Publishing Ltd. All rights reserved.

Bullboard Posts